0001773751-24-000152.txt : 20240522
0001773751-24-000152.hdr.sgml : 20240522
20240522161640
ACCESSION NUMBER: 0001773751-24-000152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240522
DATE AS OF CHANGE: 20240522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Okupe Oluyemi
CENTRAL INDEX KEY: 0001907056
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38986
FILM NUMBER: 24973487
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST., #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hims & Hers Health, Inc.
CENTRAL INDEX KEY: 0001773751
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
BUSINESS PHONE: 415-851-0195
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
FORMER COMPANY:
FORMER CONFORMED NAME: Oaktree Acquisition Corp.
DATE OF NAME CHANGE: 20190412
4
1
wk-form4_1716408990.xml
FORM 4
X0508
4
2024-05-20
0
0001773751
Hims & Hers Health, Inc.
HIMS
0001907056
Okupe Oluyemi
2269 CHESTNUT STREET, #523
SAN FRANCISCO
CA
94123
0
1
0
0
Chief Financial Officer
1
Class A Common Stock
2024-05-20
4
S
0
6900
20.0063
D
161727
D
Class A Common Stock
2024-05-21
4
M
0
28084
5.01
A
189811
D
Class A Common Stock
2024-05-21
4
S
0
31433
17.8595
D
158378
D
Class A Common Stock
2024-05-21
4
S
0
3349
17.9728
D
155029
D
Class A Common Stock
2024-05-21
4
S
0
3349
17.9517
D
151680
D
Stock Option (right to buy)
5.01
2024-05-21
4
M
0
28084
0
D
2032-02-23
Class A Common Stock
28084
936311
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.63 - $18.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.88 - $18.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.86 - $18.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
2024-05-22